The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 12K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 273 | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 2K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 9K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 35 | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 203 | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 11K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 15K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 654K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 509K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 98K | — | — |
| Dec 22, 2020 | Lampert Mark N | Insider | Conversion(C) | 2K | — | — |
| Dec 2, 2020 | OrbiMed Israel GP Ltd. | 10% Owner | Sell(S) | 103K | $21.60 | $2.2M |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Sell(S) | 13K | $26.64 | $345K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 15K | $26.17 | $393K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Sell(S) | 27 | $27.02 | $730 |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 13K | $25.88 | $335K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 9K | $25.55 | $232K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 15K | $26.48 | $397K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 4K | $25.97 | $104K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 31K | $24.53 | $760K |
| Oct 30, 2020 | Logos Global Management LP | 10% Owner | Buy(P) | 5K | $24.03 | $120K |
| Sep 11, 2020 | Lyons Gary A | Director | Grant(A) | 1K | — | $0 |
| Sep 11, 2020 | Kuwahara Jon | See Remarks | Grant(A) | 2K | — | $0 |
| Sep 11, 2020 | Gros David-Alexandre C | Chief Executive Officer, Director | Grant(A) | 18K | — | $0 |
| Sep 11, 2020 | Katkin Keith | Director | Grant(A) | 6K | — | $0 |
| Sep 11, 2020 | McBride John S. | Director | Grant(A) | 1K | — | $0 |
| Mar 19, 2020 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 200K | — | $0 |
| Mar 19, 2020 | Turkel Catherine C. | President | Grant(A) | 100K | — | $0 |
| Mar 19, 2020 | Kuwahara Jon | See Remarks | Grant(A) | 50K | — | $0 |
| Jan 14, 2020 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Sell(S) | 646K | $0.20 | $129K |
| Jan 14, 2020 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Sell(S) | 646K | $0.20 | $129K |
| Jan 14, 2020 | Chimovits Erez | Director, 10% Owner | Sell(S) | 646K | $0.20 | $129K |
| Jan 14, 2020 | Chimovits Erez | Director, 10% Owner | Sell(S) | 646K | $0.20 | $129K |
| Sep 26, 2019 | Kuwahara Jon | See Remarks | Grant(A) | 60K | — | $0 |
| Sep 26, 2019 | Turkel Catherine C. | President | Grant(A) | 75K | — | $0 |
| Sep 26, 2019 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 100K | — | $0 |
| Jul 11, 2019 | McBride John S. | Director | Grant(A) | 20K | — | $0 |
| Jul 11, 2019 | Katkin Keith | Director | Grant(A) | 20K | — | $0 |
| Jul 11, 2019 | Chimovits Erez | Director | Grant(A) | 20K | — | $0 |
| Jul 11, 2019 | Lyons Gary A | Director | Grant(A) | 20K | — | $0 |
| Jul 11, 2019 | Cohen Cheryl | Director | Grant(A) | 20K | — | $0 |
| May 21, 2019 | Turkel Catherine C. | President | Sell(S) | 2K | $1.91 | $4K |
| May 21, 2019 | Kuwahara Jon | See Remarks | Sell(S) | 1K | $1.91 | $2K |
| May 21, 2019 | Flesher Gregory J. | Chief Executive Officer, Director | Sell(S) | 3K | $1.91 | $6K |
| May 20, 2019 | Turkel Catherine C. | President | Sell(S) | 8K | $1.96 | $15K |
| May 20, 2019 | Kuwahara Jon | See Remarks | Sell(S) | 4K | $1.96 | $8K |
| May 20, 2019 | Flesher Gregory J. | Chief Executive Officer, Director | Sell(S) | 12K | $1.96 | $23K |
| May 2, 2019 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Buy(P) | 646K | — | — |
| May 2, 2019 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Buy(P) | 646K | — | — |
| May 2, 2019 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Buy(P) | 646K | $3.10 | $2.0M |
| May 2, 2019 | Chimovits Erez | Director | Buy(P) | 646K | — | — |
| May 2, 2019 | Chimovits Erez | Director | Buy(P) | 646K | — | — |
| May 2, 2019 | Chimovits Erez | Director | Buy(P) | 646K | $3.10 | $2.0M |
| Apr 30, 2019 | Yook Paul | 10% Owner | Sell(S) | 200 | $2.70 | $540 |
| Mar 14, 2019 | Turkel Catherine C. | President | Grant(A) | 50K | — | $0 |
| Mar 14, 2019 | Turkel Catherine C. | President | Grant(A) | 20K | — | $0 |
| Mar 14, 2019 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 90K | — | $0 |
| Mar 14, 2019 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 25K | — | $0 |
| Mar 14, 2019 | Kuwahara Jon | See Remarks | Grant(A) | 25K | — | $0 |
| Sep 12, 2018 | Turkel Catherine C. | President | Buy(P) | 17K | $5.02 | $83K |
| Sep 11, 2018 | Turkel Catherine C. | President | Buy(P) | 17K | $4.56 | $78K |
| Sep 5, 2018 | Turkel Catherine C. | President | Buy(P) | 805 | $3.97 | $3K |
| Jun 13, 2018 | Cohen Cheryl | Director | Grant(A) | 9K | — | $0 |
| Jun 13, 2018 | Lyons Gary A | Director | Grant(A) | 9K | — | $0 |
| Jun 13, 2018 | Katkin Keith | Director | Grant(A) | 9K | — | $0 |
| Jun 13, 2018 | McBride John S. | Director | Grant(A) | 9K | — | $0 |
| Mar 13, 2018 | Kuwahara Jon | See Remarks | Grant(A) | 12K | — | $0 |
| Mar 13, 2018 | Kuwahara Jon | See Remarks | Grant(A) | 11K | — | $0 |
| Mar 13, 2018 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 57K | — | $0 |
| Mar 13, 2018 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 31K | — | $0 |
| Mar 13, 2018 | Turkel Catherine C. | President | Grant(A) | 24K | — | $0 |
| Mar 13, 2018 | Turkel Catherine C. | President | Grant(A) | 20K | — | $0 |
| Nov 6, 2017 | Turkel Catherine C. | President | Grant(A) | 50K | — | $0 |
| Jul 10, 2017 | Kuwahara Jon | See Remarks | Grant(A) | 35K | — | $0 |
| Jun 30, 2017 | Lyons Gary A | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2017 | McBride John S. | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2017 | Cohen Cheryl | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2017 | Morrison Jodie Pope | Director | Grant(A) | 18K | — | $0 |
| Jun 30, 2017 | Katkin Keith | Director | Grant(A) | 36K | — | $0 |
| May 24, 2017 | Flesher Gregory J. | Chief Executive Officer, Director | Grant(A) | 250K | — | $0 |
| May 24, 2017 | Turkel Catherine C. | Chief Development Officer | Grant(A) | 53K | — | $0 |
| May 24, 2017 | Ocampo Christine | See Remarks | Grant(A) | 53K | — | $0 |
| May 10, 2017 | Flesher Gregory J. | Chief Executive Officer, Director | Buy(P) | 59K | $9.99 | $589K |
| May 10, 2017 | Turkel Catherine C. | Chief Development Officer | Buy(P) | 11K | $9.99 | $111K |
| May 10, 2017 | Ocampo Christine | See Remarks | Buy(P) | 10K | $9.99 | $100K |
| May 9, 2017 | OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | Grant(A) | 2.5M | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-05. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for NVUS